

Dr. Afshin Rashtian, MD
book an appointment
Dr. Afshin Rashtian, MD
Radiation Oncology
Dr. Afshin Rashtian, MD is a radiation oncologist in Riverside, CA. He is affiliated with Riverside Community Hospital. He is accepting new patients.
Locations
Riverside Radiation Oncology Medical Group
At a Glance
- Area of Expertise • Dr. Rashtian specializes in the area of Radiation Oncology. See board certifications
- Practices at Top Hospital • America’s 50 Best Hospitals for Surgical Excellence Award™ See hospitals
Experience Check
Search for experience in a specific area
Dr. Rashtian's Reviews
Likelihood to recommend Dr. Rashtian
5.0
5 Star | 100% | 100% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 0% | 0% |
Leave a review
How was your experience with Dr. Rashtian?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Rashtian to family and friends is 5 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
care philosophy
Dr. Rashtian is a leader in the field of radiation oncology with a strong national reputation. He has given talks at both the regional and national stage. He hopes to bring his academic background and expertise to the Inland Empire at Riverside...read morebiography
Dr. Afshin Rashtian is the Medical Director of Radiation Oncology at The Cancer Center Riverside Community Hospital. Previous to joining Riverside Community Hospital, he served as Assistant Professor of Clinical Radiation Oncology at USC/Norris...read moreRadiation Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Southern California Permanente Medical - Los Angeles
Residency HospitalCedar Sinai Medical Center
Internship HospitalGeorge Washington University
Medical School
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEnglish
Persian
Spanish
Feasibility, Toxicity and Outcome for MammoSite Intracavity Brachytherapy for Early Stage Breast Cancer: Preliminary results from a Single Institution: manuscript in preperation
Close or Positive Margins Following Mastectomy for Ductal Carcinoma In Situ (DCIS): Patterns of Relapse and Potential Indications for Radiotherapy, Nov. 2008
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Octeoblastic Metastases from Lung, Breast and Prostate Cancer: report of RTOG 0517, 2012
Comparison of baculovirus gp64 and Influenza HA Fusion Properties, Sep. 1997
Preoperative Stereotactic Body Radiation Therapy (SBRT)with Cyberknife for Soft Tissue Sarcoma (STS), Oct. 2012
Feasibility, Toxicity and Outcome for MammoSite Intracavity Brachytherapy for Early Stage Breast Cancer: Preliminary results from a Single Institution: Poster Presentation, 2010
Small cell Lung Cancer: A 3 Year County Hospital experience, 2012
Close or Positive Margins Following Mastectomy for Ductal Carcinoma In Situ (DCIS): Patterns of Relapse and Potential Indications for Radiotherapy, Nov. 2006
Initial Size and Dynamics of Viral Fusion Pores are a Function of the Fusion Protein Mediating Membrane Fusion, Jan. 2008
Skin Flash in IMRT Plans, Oct. 2012
A Discrete Stage of baculovirus gp64-mediated Membrane Fusion, Dec. 1999
IntraOperative Radiotherpy (IORT)for Ductal Carcinoma In Situ (DCIS)A Single Institution Study, Oct. 2012
Mammographic Findings After Intraoperative Radiotherapy of the Breast: accepted for publication, 2012
Stereotactic Body Radiotherapy using the Cyberknife Robotic Radiosurgery System for lung Cancer Primaries and Metastases to Lung, 2012
A Prospective Randomized Trial for "Good Risk" Ductal Carcinoma in situ (DCIS) Comparing Radiation (RT) to Observation (OBS): RTOG 9804, 2012
Intraoperative Radiotherapy (IORT)for Invasive Breast Cancer. A Single Institution Study, Oct. 2012
The Use and Misuse of Positron Emission Tomography in Lung Cancer evaluation, 2011
Radiation Dose to the Parotid Glands in Patients receiving whole Brain Radiation Therapy (WBRT), Oct. 2012
Dean's LIst, George Mason Unversity, 1994-1997
Affiliated Hospitals
- Recipient of 29
hospital awardsAmerica’s 50 Best Hospitals for Surgical Excellence Award™ (2025)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all awardsAmerica's 250 Best Hospitals Award™ (2025, 2024, 2023)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all patient feedbackHow patients felt about the care they received at this hospital.
79%Patients said they were given information about recovering at home5% lower than the national average
70%Patients said that doctors always listened to them and explained things well6% lower than the national average
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.